Kinoshita Tomonari, Goto Taichiro
Division of Thoracic Surgery, Japanese Red Cross Ashikaga Hospital, Tochigi 326-0843, Japan.
Lung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, Yamanashi 400-8506, Japan.
J Clin Med. 2021 Jan 10;10(2):228. doi: 10.3390/jcm10020228.
Despite complete resection, cancer recurrence frequently occurs in clinical practice. This indicates that cancer cells had already metastasized from their organ of origin at the time of resection or had circulated throughout the body via the lymphatic and vascular systems. To obtain this potential for metastasis, cancer cells must undergo essential and intrinsic processes that are supported by the tumor microenvironment. Cancer-associated inflammation may be engaged in cancer development, progression, and metastasis. Despite numerous reports detailing the interplays between cancer and its microenvironment via the inflammatory network, the status of cancer-associated inflammation remains difficult to recognize in clinical settings. In the current paper, we reviewed clinical reports on the relevance between inflammation and cancer recurrence after surgical resection, focusing on inflammatory indicators and cancer recurrence predictors according to cancer type and clinical indicators.
尽管进行了根治性切除,但在临床实践中癌症复发仍频繁发生。这表明癌细胞在切除时已经从其原发器官转移,或者已经通过淋巴和血管系统在全身循环。为了获得这种转移潜能,癌细胞必须经历由肿瘤微环境支持的基本和内在过程。癌症相关炎症可能参与癌症的发生、发展和转移。尽管有大量报告详细阐述了癌症与其微环境之间通过炎症网络的相互作用,但在临床环境中,癌症相关炎症的状态仍然难以识别。在本文中,我们回顾了关于手术切除后炎症与癌症复发相关性的临床报告,重点关注根据癌症类型和临床指标的炎症指标和癌症复发预测因素。